Loading...
Maleimide-thiol linkages alter the biodistribution of SN38 therapeutic microbubbles compared to biotin-avidin while preserving parity in tumoral drug delivery
Ingram, N. Abou-Saleh, R.H. Race, Amanda D. Bushby, R.J. Evans, S.D. Coletta, P.L.
Ingram, N.
Abou-Saleh, R.H.
Race, Amanda D.
Bushby, R.J.
Evans, S.D.
Coletta, P.L.
Publication Date
2024-03-21
End of Embargo
Supervisor
Rights
© 2024 by the authors.
Licensee MDPI, Basel, Switzerland.
This article is an open access article
distributed under the terms and
conditions of the Creative Commons
Attribution (CC BY) license (https://
creativecommons.org/licenses/by/
4.0/).
Peer-Reviewed
Yes
Open Access status
openAccess
Accepted for publication
2024-03-18
Institution
Department
Awarded
Embargo end date
Collections
Additional title
Abstract
Therapeutic microbubbles (thMBs) contain drug-filled liposomes linked to microbubbles and targeted to vascular proteins. Upon the application of a destructive ultrasound trigger, drug uptake to tumour is improved. However, the structure of thMBs currently uses powerful non-covalent bonding of biotin with avidin-based proteins to link both the liposome to the microbubble (MB) and to bind the targeting antibody to the liposome-MB complex. This linkage is not currently FDA-approved, and therefore, an alternative, maleimide-thiol linkage, that is currently used in antibody-drug conjugates was examined. In a systematic manner, vascular endothelial growth factor receptor 2 (VEGFR2)-targeted MBs and thMBs using both types of linkages were examined for their ability to specifically bind to VEGFR2 in vitro and for their ultrasound imaging properties in vivo. Both showed equivalence in the production of the thMB structure, in vitro specificity of binding and safety profiles. In vivo imaging showed subtle differences for thMBs where biotin thMBs had a faster wash-in rate than thiol thMBs, but thiol thMBs were longer-lived. The drug delivery to tumours was also equivalent, but interestingly, thiol thMBs altered the biodistribution of delivery away from the lungs and towards the liver compared to biotin thMBs, which is an improvement in biosafety.
Version
Published version
Citation
Ingram N, Abou-Saleh RH, Race AD et al (2024) Maleimide-thiol linkages alter the biodistribution of SN38 therapeutic microbubbles compared to biotin-avidin while preserving parity in tumoral drug delivery. Pharmaceutics. 16(3): 434.
Link to publisher’s version
Link to published version
Link to Version of Record
Type
Article